Amphastar Pharmaceuticals, Inc.
Nasdaq · CIK 0001297184 · Fiscal year end 1231
Latest reported period: Latest published period
Recent financials
| Metric | Current | Prior | Change |
|---|
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-07-13 | 0002141303-26-000005 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-06-03 | 0001611283-26-000003 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-06-03 | 0002075974-26-000003 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-06-03 | 0001866024-26-000003 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-06-03 | 0001047579-26-000003 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-06-03 | 0001379941-26-000003 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-06-03 | 0001033511-26-000003 |
| 10-Q | Amphastar Pharmaceuticals, Inc. | 2026-05-07 | 0001297184-26-000033 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-17 | 0001263136-26-000010 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-17 | 0000889740-26-000007 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-17 | 0001743927-26-000010 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-17 | 0001645326-26-000010 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-11 | 0001263136-26-000008 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-11 | 0001645326-26-000008 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-11 | 0001743927-26-000008 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-11 | 0000889740-26-000005 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-10 | 0001263136-26-000006 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-10 | 0001645326-26-000006 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-10 | 0001743927-26-000006 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-10 | 0000889740-26-000003 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-06 | 0001743927-26-000003 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-06 | 0001263136-26-000003 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-06 | 0001104659-26-024842 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2026-03-06 | 0001645326-26-000003 |
| 10-K | Amphastar Pharmaceuticals, Inc. | 2026-02-26 | 0001297184-26-000009 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2025-12-18 | 0001645326-25-000004 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2025-12-15 | 0001611286-25-000011 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2025-11-25 | 0001047579-25-000006 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2025-11-17 | 0001611286-25-000009 |
| 10-Q | Amphastar Pharmaceuticals, Inc. | 2025-11-06 | 0001297184-25-000064 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2025-11-05 | 0001611286-25-000007 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2025-10-02 | 0001611286-25-000005 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2025-09-03 | 0001415889-25-023538 |
| 10-Q | Amphastar Pharmaceuticals, Inc. | 2025-08-07 | 0001297184-25-000050 |
| 4 | Amphastar Pharmaceuticals, Inc. | 2025-08-04 | 0001415889-25-020987 |